Key Points
- CFO Robert Phelan sold 2,186 Adtalem shares at an average price of $135.15, generating approximately $295,438. The transaction was conducted under a pre-arranged Rule 10b5-1 plan, leaving him with 48,306 shares.
- Adtalem reported quarterly EPS of $2.09, beating the $1.90 analyst consensus, on revenue of $501.38 million. The company set fiscal 2027 EPS guidance at $8.90–$9.15.
- Analyst sentiment remains favorable, with a consensus “Moderate Buy” rating and a $155 price target, versus the stock’s reported opening price of $125.98.
Adtalem Global Education Inc. (NYSE:CVSA - Get Free Report) CFO Robert Phelan sold 2,186 shares of the firm's stock in a transaction on Friday, August 7th. The shares were sold at an average price of $135.15, for a total value of $295,437.90. Following the transaction, the chief financial officer owned 48,306 shares in the company, valued at approximately $6,528,555.90. This represents a 4.33% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Adtalem Global Education Price Performance
NYSE:CVSA opened at $125.98 on Wednesday. Adtalem Global Education Inc. has a 1-year low of $86.97 and a 1-year high of $156.26. The business has a 50-day simple moving average of $124.90. The stock has a market capitalization of $4.29 billion, a price-to-earnings ratio of 17.89, a PEG ratio of 0.95 and a beta of 0.62. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.45.
Adtalem Global Education (NYSE:CVSA - Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $2.09 EPS for the quarter, beating analysts' consensus estimates of $1.90 by $0.19. Adtalem Global Education had a net margin of 12.87% and a return on equity of 20.88%. The business had revenue of $501.38 million for the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. Sell-side analysts anticipate that Adtalem Global Education Inc. will post 8.99 EPS for the current fiscal year.
Wall Street Analyst Weigh In
A number of equities analysts recently commented on CVSA shares. Barrington Research reissued an "outperform" rating and issued a $170.00 price objective on shares of Adtalem Global Education in a research note on Monday, June 8th. Truist Financial lifted their price target on Adtalem Global Education from $130.00 to $140.00 and gave the company a "buy" rating in a report on Monday, May 11th. Wall Street Zen raised Adtalem Global Education from a "hold" rating to a "buy" rating in a research report on Saturday. Finally, Weiss Ratings restated a "hold (c+)" rating on shares of Adtalem Global Education in a research note on Friday, May 22nd. Two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, Adtalem Global Education presently has a consensus rating of "Moderate Buy" and a consensus price target of $155.00.
Get Our Latest Report on CVSA
About Adtalem Global Education
(
Get Free Report)
Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.
Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
